Bacterial ribonuclease III (RNase III) can affect RNA structure and gene expression in either of two ways: as a processing enzyme that cleaves double-stranded (ds) RNA, or as a binding protein that binds but does not cleave dsRNA. We previously proposed a model of the catalytic complex of RNase III with dsRNA based on three crystal structures, including the endonuclease domain of RNase III with and without bound metal ions and a dsRNA binding protein complexed with dsRNA. We also reported a noncatalytic assembly observed in the crystal structure of an RNase III mutant, which binds but does not cleave dsRNA, complexed with dsRNA. We hypothesize that the RNase III•dsRNA complex can exist in two functional forms, a catalytic complex and a noncatalytic assembly, and that in between the two forms there may be intermediate states. Here, we present four crystal structures of RNase III complexed with dsRNA, representing possible intermediates.
Introduction
Ribonuclease III (RNase III) belongs to a superfamily of double-stranded RNA (dsRNA) endoribonucleases (Court, 1993; Robertson et al., 1968) and has been found in most studied prokaryotes and eukaryotes (Court, 1993; Filippov et al., 2000; Krainer, 1997; Nicholson, 1996 Nicholson, , 1999 . It plays important roles in RNA processing, viral infection (Robertson et al., 1968) , and posttranscriptional gene expression control (Court, 1993 1B) . Second, in the catalytic form, the two dsRBDs interact with the same dsRNA helix ( Figure 1A ). In the noncatalytic form, however, each dsRBD binds a different dsRNA helix ( Figure 1B) . Third, in the catalytic form the dsRNA substrate is bound in the catalytic valley ( Figure 1A) , whereas in the noncatalytic form the two dsRNA duplexes are completely out of the valley ( Figure 1B ). These variations are readily explained because the linker between the endoND and dsRBD is flexible. Figure 1C depicts the crystal structure of ligand-free RNase III from Thermotoga maritima (TmRNase III; Protein Data Bank code 1O0W), demonstrating that the seven-residue linker between the endoND and dsRBD ( 145 EGRVKKD 151 and 162 KGEMLFD 168 in Aa-and Tm-RNase III, respectively) is flexible and allows the dsRBD to rotate and shift dramatically with respect to the endoND. Genetic studies have demonstrated that residues in the linker are essential for the dsRNA processing activity (Inada and Nakamura, 1995) .
When RNase III is bound to dsRNA, we expect at least two stable conformations represented by our model of Aa-RNase III•dsRNA ( Figure 1A ) on the one hand and by the crystal structure of Aa-E110K•dsRNA ( Figure 1B) on the other. These two modes of dsRNA binding would affect posttranscriptional gene expression by distinct mechanisms. As a dsRNA-processing enzyme, RNase III binds dsRNA in the valley ( Figure  1A) where the active centers are located, allowing the substrate to be processed. As a dsRNA binding protein, RNase III binds dsRNA outside of the catalytic valley ( Figure 1B ) and therefore cannot process the bound dsRNA but still influences gene expression (Calin-Jage- Our working hypothesis is that, in vivo, the RNase III dimer first binds a dsRNA with one of its two dsRBDs. If the dsRNA is of a sufficient length (at least two helical turns) and does not contain antideterminants (see below for details), an isomerization to the RNA-processing form may occur. This isomerization step, which was previously suggested using an active enzyme (Campbell et al., 2002), is essentially dependent on the flexible linker located between the endoND and the dsRBD (Blaszczyk et al., 2004) , and is likely to be favored by an increase in binding affinity for the dsRNA due to its interaction with the other dsRBD and the catalytic valley of the endoNDs. In this study, we report four crystal structures of wild-type Aa-RNase III and two mutants (E110K and E110Q), each complexed with dsRNA. These structures appear to represent intermediate states of the RNase III•dsRNA complex leading to the two functional forms described above. Figure 2D) show that a dimeric RNase III can bind one dsRNA helix. In three out of the four complexes, the dsRNA is not 3C and 3D ). An important difference is observed between the pseudoduplex formed by dsRNA 2-2 and those of the other dsRNAs: the former adopts a regular A form helix ( Figure 3A) , whereas the others exhibit a kink between the stacking RNA duplexes (Figures 3B-3D) , including also the pseudoduplex formed by dsRNA 1-1 (Blaszczyk et al., 2004). The structural basis for this difference could be the two-nucleotide 3# overhang at each end of dsRNA 2-2, which may facilitate the formation of an A form duplex. Duplexes 1-1, 3-3, and 4-4 do not have the two-nucleotide 3# overhang, and may result in the irregularity at the stacking points. Therefore, a regular A form duplex is perhaps necessary for the dsRNA to interact with two dsRBDs in a symmetric manner.
Results and

The Flexible Linker Is Essential for the Function of RNase III
As shown in Figure 1 , the conformational change of RNase III depends upon a seven-residue linker ( 145 EGRVKKD 151 and 149 PGDKQKD 155 in Aa-and EcRNase III, respectively) between the endoND and dsRBD. It has been shown that the Q153P substitution in Ec-RNase III abolishes its RNA cleavage activity without affecting its ability to bind dsRNA (Inada and Nakamura, 1995). Although this residue is not conserved among bacterial RNase III proteins, the introduction of a Pro residue in the middle of the linker probably reduces its flexibility, which is probably essential for RNA processing activity. We suggest that the structural differences (Figure 2 Figure 2D, this work) . In all five structures, the flexible linker is well defined, suggesting that the conformations observed in the crystal lattice are relatively stable, a characteristic feature of intermediates.
We also expect that the end-to-end stacking of the 10-mer (dsRNA 1-1), 11-mer (dsRNA 2-2), and 12-mer (dsRNA 3-3 and 4-4) dsRNA elements affects the stability of the entire structure. Because the concentration of these RNA elements is initially quite high under crystallization conditions, one might expect the independent binding of a dsRBD to two stacked RNA elements to occur, mimicking an RNA duplex with a total length ranging from 20 to 24 bp (Figure 2 initial recognition of the substrate (Bardwell et al., 1989; Inada and Nakamura, 1995), but not due to the formation of a noncatalytic assembly as described above.
Experimental Procedures
Construction of the Aa-E110Q Expression Vector
The plasmid expression vector that was used to produce the Aa- 
Protein Expression and Purification
The Aa-E110K protein was overproduced in E. coli and purified as described (Blaszczyk et al., 2004) . The Aa-E110Q mutant was overproduced in E. coli BL21(DE3) CodonPlus-RIL cells (Stratagene, La Jolla, CA). Single antibiotic-resistant colonies were used to inoculate 100 ml of Luria-Bertani (LB) (Miller, 1972) supplemented with 100 g/ml ampicillin and 30 g/ml chloramphenicol. These cultures were grown with shaking (225 rev./min) to saturation overnight at 37°C and then diluted 33-fold into six 1 L preparations of fresh media resulting in an initial optical density of approximately OD 600 nm = 0.15. When the cells reached early log phase (OD 600 nm w0.5), the temperature was reduced to 30°C and isopropyl β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM. The cultures were incubated for 4 hr and pelleted by centrifugation at 5000 × g for 10 min at 4°C. The cell pellet was stored at −80°C.
Unless otherwise stated, all procedures were performed at 4°C. E. coli cell paste was suspended in ice-cold 50 mM sodium phosphate (pH 8.0), 25 mM NaCl buffer (buffer A) containing 1 mM benzamidine and Complete EDTA-free protease inhibitor cocktail tablets (Roche, Indianapolis, IN), and disrupted with an APV Gaulin model G1000 homogenizer (APV USA, Lake Mills, WI) at 10,000 psi. The homogenate was centrifuged at 30,000 × g for 30 min, and the supernatant was heat treated at 80°C for 20 min. After pelleting the insoluble material by centrifugation, the supernatant was filtered through a 0.22 m polyethersulfone membrane and applied to a HiPrep 16/10 SP FF column (Amersham Biosciences, Piscataway, NJ) equilibrated with buffer A. The column was washed with ten column volumes of buffer A and eluted with a linear gradient of NaCl from 25 mM to 1 M. Fractions containing recombinant protein were pooled, concentrated using an Amicon YM10 membrane (Millipore, Billerica, MA), and fractionated on a HiLoad 26/60 Superdex 75 pg column (Amersham Biosciences) equilibrated in 25 mM Tris (pH 7.2), 600 mM NaCl buffer. Aa-RNase III-containing fractions (330-560 mM NaCl) were pooled and diluted with a 50 mM Tris (pH 7.5) buffer to reduce the NaCl concentration to 300 mM. The sample was applied to a 15 ml AGPoly(I)•Poly(C) Type 6 column (Amersham Biosciences) equilibrated with 50 mM Tris (pH 7.5), 300 mM NaCl buffer. The column was washed extensively with equilibration buffer until a stable baseline was reached and then eluted with a linear gradient of NaCl from 0.3 to 1 M. Fractions containing recombinant protein were pooled, concentrated, and subjected to a second round of size exclusion chromatography as described above. The final product was diluted with a 25 mM Tris (pH 7.2) buffer to reduce the NaCl concentration to 300 mM and concentrated to 17.4 mg/ml (determined spectrophotometrically using a molar extinction coefficient of 24,180 M −1 cm −1
). Aliquots were flash-frozen in liquid nitrogen and stored at −80°C until use. The Aa-RNase III protein was judged to be >95% pure by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The molecular weight was confirmed by electrospray mass spectrometry.
The purification protocol for E110Q was identical to that for E110K. For E110Q, the final concentration was 18.1 mg/ml. The molar extinction coefficient for E110Q was the same as for E110K ( 
